Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

ERT and the renin-angiotensin system in postmenopausal women

Jan. 24, 1997

ACCORD study results reported in Circulation

Jan. 24, 1997

TBC receives patent coverage for endothelin antagonists

Jan. 23, 1997

Smoking definitively linked to cardiovascular morbidity and mortality

Jan. 23, 1997

Raloxifene for inhibition of vascular smooth muscle cell migration

Jan. 23, 1997

Acadesine reduces CABG-associated mortality and morbidity

Jan. 22, 1997

New endothelin antagonists from Zeneca

Jan. 22, 1997

New cardiovascular agents from Sigma-Tau

Jan. 21, 1997

Suntory reports new agents for circulatory disorders

Jan. 21, 1997

Medtronic's arrhythmia management device enters clinic

Jan. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...